Ever Fortune. AI Co

Ever Fortune. AI Co Acquisitions (Net)

The Acquisitions (Net) of Ever Fortune. AI Co (6841.TWO) as of Oct 22, 2026 is -60.31 M TWD. In the previous year, Acquisitions (Net) was -125.17 M TWD — a change of -51.82% (higher).

Acquisitions (Net)

-60.31 MTWD

YoY

-51.82%

Last updated:

Acquisitions (Net) of Ever Fortune. AI Co is 2024 -60.31 M TWD. Acquisitions (Net) of Ever Fortune. AI Co was 2023 -125.17 M TWD. It decreases by -51.82% higher compared to the previous year.

The Ever Fortune. AI Co Acquisitions (Net) history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Acquisitions (Net)
Date
Acquisitions (Net)
Jan 1, 2018
-95.85 M TWD
Jan 1, 2019
-430.01 M TWD
Jan 1, 2020
-869.62 M TWD
Jan 1, 2021
4.25 M TWD
Jan 1, 2022
71.98 M TWD
Jan 1, 2023
-125.17 M TWD
Jan 1, 2024
-60.31 M TWD
The Ever Fortune. AI Co Acquisitions (Net) history
YEARAcquisitions (Net)YoY
-60.31 MTWD-51.82%
-125.17 MTWD-273.89%
71.98 MTWD+1,594.14%
4.25 MTWD-100.49%
-869.62 MTWD+102.23%
-430.01 MTWD+348.62%
-95.85 MTWD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Ever Fortune. AI Co Stock analysis

What does Ever Fortune. AI Co do? Ever Fortune.AI Co., Ltd. generates revenue through the sale of medical AI software products and customized technology solutions. The company offers medical big data platforms, cloud biomedical services, and AI-driven tools such as the radiographic bone age-assisted interpretation system, ultrasound breast tumor auxiliary classification system, and CT liver cancer metastasis risk management system. These products target healthcare providers, hospitals, and medical institutions seeking advanced diagnostic and analytical capabilities. The firm's focus on specialized medical AI applications ensures consistent demand from clients requiring precision in radiology, oncology, and cardiology. The company's revenue streams include the provision of medical AI data analysis services and tailored AI technology solutions for healthcare facilities. Products like the liver fibrosis evaluation system and irregular cardiac fibrillation interpretation system are designed to address specific clinical needs, enhancing diagnostic accuracy. Healthcare organizations, particularly those in radiology and cardiology departments, purchase these tools to improve patient outcomes and operational efficiency. Ever Fortune.AI's business model centers on delivering high-value AI solutions for medical diagnostics, with a portfolio that includes both standardized products and custom-developed systems. The firm's offerings cater to hospitals and medical institutions looking to integrate AI into their diagnostic workflows. By focusing on niche medical applications, the company establishes itself as a specialized provider in the healthcare technology sector. Ever Fortune. AI Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Ever Fortune. AI Co stock

Acquisitions (Net) of Ever Fortune. AI Co is -60.31 M TWD in 2024.

Acquisitions (Net) of Ever Fortune. AI Co changed from -125.17 M TWD to -60.31 M TWD, representing a -51.82% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Acquisitions (Net) Ever Fortune. AI Co since 2006 – with annual values, charts, and detailed analysis.

Net acquisitions represent the cash spent on acquiring other businesses, net of divestitures. Large acquisitions can transform a company's growth trajectory.

Acquisitions (Net)'s TWD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Acquisitions (Net)'s Ever Fortune. AI Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Ever Fortune. AI Co

All Key Metrics — Ever Fortune. AI Co